Warfarin therapy
234 results
201 - 234Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
Pentasaccharides for the treatment of deep vein thrombosis
ACCP guidelines for antithrombotics in atrial fibrillation
Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty: Cochrane systematic review
Chronic heart failure
Transient ischaemic attack (TIA)
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
Aspirin is no different than other anticoagulants for VTE prevention after joint replacement surgery
Acute coronary syndrome
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks: Cochrane systematic review
For atrial fibrillation with ACS or PCI, apixaban plus clopidogrel (without aspirin) is preferred (AUGUSTUS)
Clostridioides difficile diarrhoea
Interventions for preventing thrombosis in solid organ transplant recipients
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
Drugs used in alcohol dependence
Electrical cardioversion
Antiplatelet agents and anticoagulants for hypertension
D-dimer can identify high-risk group for extended anticoagulation (PROLONG)
Preoperative assessment
Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions
Cerebral infarction (ischaemic stroke)
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
The DOAC score determines bleeding risk for patients with atrial fibrillation who take a direct-acting oral anticoagulant
Antitubercular medication in ambulatory care
Prevention of atrial fibrillation
Antiplatelet and anticoagulation for patients with prosthetic heart valves
Treatment of dyslipidaemias
Non-steroid agents for idiopathic pulmonary fibrosis: Cochrane systematic review
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end‐stage kidney disease
Use of medication during pregnancy